Literature DB >> 22544928

Prostaglandin E2 affects T cell responses through modulation of CD46 expression.

Karoline Kickler1, Kathryn Maltby, Siobhán Ni Choileain, Jillian Stephen, Sheila Wright, David A Hafler, Henry N Jabbour, Anne L Astier.   

Abstract

The ubiquitous protein CD46, a regulator of complement activity, promotes T cell activation and differentiation toward a regulatory Tr1-like phenotype. The CD46-mediated differentiation pathway is defective in several chronic inflammatory diseases, underlying the importance of CD46 in controlling T cell function and the need to understand its regulatory mechanisms. Using an RNA interference-based screening approach in primary T cells, we have identified that two members of the G protein-coupled receptor kinases were involved in regulating CD46 expression at the surface of activated cells. We have investigated the role of PGE(2), which binds to the E-prostanoid family of G protein-coupled receptors through four subtypes of receptors called EP 1-4, in the regulation of CD46 expression and function. Conflicting roles of PGE(2) in T cell functions have been reported, and the reasons for these apparent discrepancies are not well understood. We show that addition of PGE(2) strongly downregulates CD46 expression in activated T cells. Moreover, PGE(2) differentially affects T cell activation, cytokine production, and phenotype depending on the activation signals received by the T cells. This was correlated with a distinct pattern of the PGE(2) receptors expressed, with EP4 being preferentially induced by CD46 activation. Indeed, addition of an EP4 antagonist could reverse the effects observed on cytokine production after CD46 costimulation. These data demonstrate a novel role of the PGE(2)-EP4 axis in CD46 functions, which might at least partly explain the diverse roles of PGE(2) in T cell functions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544928      PMCID: PMC3758685          DOI: 10.4049/jimmunol.1103090

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity.

Authors:  Vinodh Pillai; Nitin J Karandikar
Journal:  Blood       Date:  2008-01-01       Impact factor: 22.113

2.  ADAM10-mediated release of complement membrane cofactor protein during apoptosis of epithelial cells.

Authors:  Juha Hakulinen; Jorma Keski-Oja
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

3.  Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis.

Authors:  Yoshiyasu Esaki; Youxian Li; Daiji Sakata; Chengcan Yao; Eri Segi-Nishida; Toshiyuki Matsuoka; Kazuhiko Fukuda; Shuh Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  Changes in the G-protein-coupled receptor desensitization machinery during relapsing-progressive experimental allergic encephalomyelitis.

Authors:  Anne Vroon; Maria Stella Lombardi; Annemieke Kavelaars; Cobi J Heijnen
Journal:  J Neuroimmunol       Date:  2003-04       Impact factor: 3.478

5.  Agonist-induced phosphorylation by G protein-coupled receptor kinases of the EP4 receptor carboxyl-terminal domain in an EP3/EP4 prostaglandin E(2) receptor hybrid.

Authors:  F Neuschäfer-Rube; M Oppermann; U Möller; U Böer; G P Püschel
Journal:  Mol Pharmacol       Date:  1999-08       Impact factor: 4.436

6.  Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.

Authors:  Anne L Astier; Gregory Meiffren; Samuel Freeman; David A Hafler
Journal:  J Clin Invest       Date:  2006-11-09       Impact factor: 14.808

7.  RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels.

Authors:  Anne L Astier; Gaëlle Beriou; Thomas M Eisenhaure; Stephen M Anderton; David A Hafler; Nir Hacohen
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

8.  STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' ends.

Authors:  H Dan Lewis; Ashley Winter; Thomas F Murphy; Snehlata Tripathi; Virendra N Pandey; Beverly E Barton
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

9.  IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis.

Authors:  Ivan Martinez-Forero; Ricardo Garcia-Munoz; Sara Martinez-Pasamar; Susana Inoges; Ascensión Lopez-Diaz de Cerio; Ricardo Palacios; Jorge Sepulcre; Beatriz Moreno; Zaira Gonzalez; Begoña Fernandez-Diez; Ignacio Melero; Maurizio Bendandi; Pablo Villoslada
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

Review 10.  The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology.

Authors:  David M Sansom; Lucy S K Walker
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

View more
  9 in total

1.  Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1.

Authors:  Kirsten M Hooper; Jui-Hung Yen; Weimin Kong; Kate M Rahbari; Ping-Chang Kuo; Ana M Gamero; Doina Ganea
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

2.  Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells.

Authors:  David M Kofler; Alexander Marson; Margarita Dominguez-Villar; Sheng Xiao; Vijay K Kuchroo; David A Hafler
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

3.  Calcitriol modulates the CD46 pathway in T cells.

Authors:  Karoline Kickler; Siobhan Ni Choileain; Anna Williams; Anna Richards; Anne L Astier
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

4.  Monocyte:T-cell interaction regulates human T-cell activation through a CD28/CD46 crosstalk.

Authors:  Lauren Charron; Axelle Doctrinal; Siobhan Ni Choileain; Anne L Astier
Journal:  Immunol Cell Biol       Date:  2015-03-19       Impact factor: 5.126

Review 5.  Complement as a regulator of adaptive immunity.

Authors:  Justin Killick; Gregoire Morisse; Dirk Sieger; Anne L Astier
Journal:  Semin Immunopathol       Date:  2017-08-25       Impact factor: 9.623

Review 6.  The Impact of Acute or Chronic Alcohol Intake on the NF-κB Signaling Pathway in Alcohol-Related Liver Disease.

Authors:  Aleksander J Nowak; Borna Relja
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

7.  The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation.

Authors:  Konstantin Knoblich; Sara Cruz Migoni; Susan M Siew; Elizabeth Jinks; Baksho Kaul; Hannah C Jeffery; Alfie T Baker; Muath Suliman; Katerina Vrzalikova; Hisham Mehenna; Paul G Murray; Francesca Barone; Ye H Oo; Philip N Newsome; Gideon Hirschfield; Deirdre Kelly; Steven P Lee; Biju Parekkadan; Shannon J Turley; Anne L Fletcher
Journal:  PLoS Biol       Date:  2018-09-04       Impact factor: 8.029

8.  PGE2 displays immunosuppressive effects during human active tuberculosis.

Authors:  Joaquín Miguel Pellegrini; Candela Martin; María Paula Morelli; Julieta Aylen Schander; Nancy Liliana Tateosian; Nicolás Oscar Amiano; Agustín Rollandelli; Domingo Juan Palmero; Alberto Levi; Lorena Ciallella; María Isabel Colombo; Verónica Edith García
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

9.  Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity.

Authors:  Leland Metheny; Saada Eid; Patiwet Wuttisarnwattana; Jeffery J Auletta; Chen Liu; Alana Van Dervort; Conner Paez; ZhengHong Lee; David Wilson; Hillard M Lazarus; Robert Deans; Wouter Vant Hof; Yiouli Ktena; Kenneth R Cooke
Journal:  Stem Cells       Date:  2021-07-28       Impact factor: 6.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.